跳至主要内容
临床试验/NCT01860521
NCT01860521已完成不适用

Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Second Trimester Voluntary Termination of Pregnancy Analgesia: a Randomized Study.

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
104
试验地点
1
主要终点
Incidence of Motor Block

研究概览

简要总结

This study included women who underwent voluntary second trimester termination of pregnancy. Patients were randomized to programmed intermittent epidural anesthetic bolus or continuous epidural infusion for pain analgesia. In this randomized, double-blind study, the investigators assess the incidence of motor block (primary outcome), degree of satisfaction of the patients, total levobupivacaine and sufentanil consumption and adverse events (secondary outcomes) between the two study groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age ≥ 18 years
  • pregnancy at second trimester
  • willingness of voluntary interrupt the pregnancy
  • comprehension of Italian Language
  • baseline pain score ≥ 30 on a 100-mm visual analog pain scale (VAPS)

排除标准

  • contraindication to epidural analgesia and to narcotics
  • history of drug abuse or chronic use
  • maternal disease (such as severe asthma, cardiac, liver or kidney disease)
  • inability to comprehend or comply with the analgesia pain management procedures.

研究组 & 干预措施

Programmed Intermittent Epidural Bolus

Active Comparator

干预措施: Programmed Intermittent Epidural Bolus (Procedure)

Programmed Intermittent Epidural Bolus

Active Comparator

干预措施: Procedure of interruption of pregnancy (Procedure)

Programmed Intermittent Epidural Bolus

Active Comparator

干预措施: Drug used for analgesia procedures (Drug)

Programmed Intermittent Epidural Bolus

Active Comparator

干预措施: Pump for programmed intermittent bolus. (Device)

Programmed Intermittent Epidural Bolus

Active Comparator

干预措施: Drug used for termination of pregnancy procedure. (Drug)

Continuous Epidural Infusion

Active Comparator

干预措施: Continuous Epidural Infusion (Procedure)

Continuous Epidural Infusion

Active Comparator

干预措施: Procedure of interruption of pregnancy (Procedure)

Continuous Epidural Infusion

Active Comparator

干预措施: Drug used for analgesia procedures (Drug)

Continuous Epidural Infusion

Active Comparator

干预措施: Pump for continuous epidural infusion. (Device)

Continuous Epidural Infusion

Active Comparator

干预措施: Drug used for termination of pregnancy procedure. (Drug)

结局指标

主要结局

Incidence of Motor Block

时间窗: Assessed every hour from starting the analgesia procedure (up to 66 hours from starting of the procedure).

The assessment of the degree of motor block was performed in the right and left lower extremities using the Breen modified Bromage score: 1 = complete block (unable to move feet or knees), 2 = almost complete block (able to move feet only), 3 = partial block (just able to move knees), 4 = detectable weakness of hip flexion while supine (between scores 3 and 5), 5 = no detectable weakness of hip flexion while supine (full flexion of knees), and 6 = able to stand and to perform partial knee bend. Patients with a Bromage score \< 6 were considered to have motor block.

次要结局

  • Degree of Satisfaction of the Patients With the Analgesia Procedure(At discharge from the hospital (up to 72 hours from starting of the procedure).)
  • Total Levobupivacaine Consumption(At the moment of fetal expulsion (up to 66 hours from starting of the procedure).)
  • Total Sufentanil Consumption.(During the whole analgesia procedure (assessed between the starting of the procedure until 66 hours).)

研究者

发起方
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Umberto Leone Roberti Maggiore

Principal Investigator, Research Fellow.

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

研究点 (1)

Loading locations...

相似试验